2658-6533Research Results in Biomedicine2658-653310.18413/2658-6533-2020-6-1-0-81965Pharmacology<strong>Pharmacological effects of the combined administration of a small dose of Acetylsalicylic acid and methyldopa in ADMA-like preeclampsia</strong><br /> &nbsp;<strong>Pharmacological effects of the combined administration of a small dose of Acetylsalicylic acid and methyldopa in ADMA-like preeclampsia</strong><br /> &nbsp;SeverinovaOlga V.SeverinovaOlga V.frendic@mail.ruLazarevaGalina A.LazarevaGalina A.akush.fpo@gmail.comZhilinkovaLyudmila A.ZhilinkovaLyudmila A.l_zhilinkova@mail.ruGureevaAnastasia V.GureevaAnastasia V.nastasyi.207@gmail.com20206100

Background: Hypertensive disorders, in particular preeclampsia, which accounts for 2 to 8% of the total number of pregnancies in the world, are one of the leading causes of serious complications, prolonged disability and death in mothers and babies. In the structure of perinatal mortality, hypertensive disorders during pregnancy account for up to 25% of the total number of cases, and also occupy the leading places in the structure of causes of maternal mortality. The aim of the study: to study the protective activity of a small dose of acetylsalicylic acid and its combination with methyldopa in the correction of ADMA-like preeclampsia. Materials and methods: The study was performed on 150 female Wistar rats weighing 250-300 g. An ADMA-like model of preeclampsia was reproduced in the experiment. The following parameters were used to assess emerging morphofunctional disorders like blood pressure, coefficient of endothelial dysfunction, microcirculation in the placenta, proteinuria, fluid content in the greater omentum, concentration of final metabolites in blood plasma, fetal morphometric parameters. Results: When assessing morphofunctional disorders in animals with ADMA-like preeclampsia, the study has revealed a positive effect of a small dose of acetylsalicylic acid in combination with methyldopa. Conclusion: The combined administration of a small dose of acetylsalicylic acid and methyldopa has a pronounced protective activity in the correction of morphofunctional disorders in animals with ADMA-like preeclampsia and is a promising direction in the treatment of hypertensive disorders during pregnancy.

Background: Hypertensive disorders, in particular preeclampsia, which accounts for 2 to 8% of the total number of pregnancies in the world, are one of the leading causes of serious complications, prolonged disability and death in mothers and babies. In the structure of perinatal mortality, hypertensive disorders during pregnancy account for up to 25% of the total number of cases, and also occupy the leading places in the structure of causes of maternal mortality. The aim of the study: to study the protective activity of a small dose of acetylsalicylic acid and its combination with methyldopa in the correction of ADMA-like preeclampsia. Materials and methods: The study was performed on 150 female Wistar rats weighing 250-300 g. An ADMA-like model of preeclampsia was reproduced in the experiment. The following parameters were used to assess emerging morphofunctional disorders like blood pressure, coefficient of endothelial dysfunction, microcirculation in the placenta, proteinuria, fluid content in the greater omentum, concentration of final metabolites in blood plasma, fetal morphometric parameters. Results: When assessing morphofunctional disorders in animals with ADMA-like preeclampsia, the study has revealed a positive effect of a small dose of acetylsalicylic acid in combination with methyldopa. Conclusion: The combined administration of a small dose of acetylsalicylic acid and methyldopa has a pronounced protective activity in the correction of morphofunctional disorders in animals with ADMA-like preeclampsia and is a promising direction in the treatment of hypertensive disorders during pregnancy.

acetylsalicylic acidmethyldopamicrocirculationischemic disorders in the placentaacetylsalicylic acidmethyldopamicrocirculationischemic disorders in the placentaСписок литературыGrebennik TK, Ryabinkina IN, Pavlovich SV, et al. [Statistics of preeclampsia and eclampsia]. In: [Mother and child]. Proceedings of the VIII Regional scientific forum. Sochi; 163-164.Russian.Yakushev VI, Pokrovskii MV. Cardiovascular effects of an arginase II selective inhibitor. Research Result: Pharmacology and Clinical Pharmacology. 2016;2(3):28-46. DOI: 10.18413/2500-235X-2016-2-3-28-45Nguyen MC, Park JT, Jeon YG, et al. Arginase inhibition restores peroxynitrite-induced endothelial dysfunction via L-Arginine-dependent endothelial nitric oxide synthase phosphorylation. Med J. 2016 Nov;57(6):1329-1338. DOI: https://doi.org/10.3349/ymj.2016.57.6.1329Gureev VV. New approaches of morfofunktional pharmacological correction of violations of cardiovascular system in experimental preeclampsia. Research Results in Pharmacology. 2016;2(3):11-27. DOI: 10.18413/2500-235X-2016-2-3-11-27Stupakova EG, Lazareva GA, Gureev VV, et al. L-NAME-induced Preeclampsia: correction of functional disorders of the hemostasis system with Resveratrol and Nicorandil. Research Results in Pharmacology. 2019;5(2):1-12. DOI: https://doi.org/10.3897/rrpharmacology.5.35316Ramos JGL, Sass N, Costa SHM. Preeclampsia. Rev Bras Ginecol Obstet. 2017 Sep;39(9):496-512. DOI: 10.1055/s-0037-1604471AlSheeha MA, Alaboudi RS, Alghasham MA, et al. Platelet count and platelet indices in women with preeclampsia. Vasc Health Risk Manag. 2016 Nov 21;12:477-480. DOI: 10.2147/VHRM.S120944Kohli S, Ranjan S, Hoffmann J, et al. Maternal extracellular vesicles and platelets promote preeclampsia via inflammasome activation in trophoblasts. Blood. 2016 Oct 27;128(17):2153-2164. DOI: https://doi.org/10.1182/blood-2016-03-705434Juan P, Stefano G, Antonella S, et al. Platelets in pregnancy.J Prenat Med. 2011 Oct-Dec;5(4):90-92.Lysenkov SP, Myasnikova VV, Ponomarev VV. [Emergency conditions and anesthesia in obstetrics. Clinical pathophysiology and pharmacotherapy]. SPb.: ALBI-SPb; 2004. Russian.LeFevre ML. Low-dose aspirin use for the prevention of morbidity and mortality from preeclampsia: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2014 Dec 2;161(11):819-26. DOI: 10.7326/M14-1884K&auml;ehne LV, Lundin ICR. Treatment with low-dose acetylsalicylic acid can reduce risk of pre-eclampsia in high-risk pregnant women. Ugeskr Laeger. 2017 Apr 3;179(14):V07160511.Sarma A, Scott NS. Aspirin Use in Women: Current Perspectives and Future Directions. Curr. Atheroscler. Rep. 2016;18(12):74. DOI: https://doi.org/10.1007/s11883-016-0630-1Mone F, Mulcahy C, McParland P, et al. ТShould we recommend universal aspirin for all pregnant women? Am. J. Obstet. Gynecol. 2017 Feb;216(2):141. DOI: https://doi.org/10.1016/j.ajog.2016.09.086Sahin S, Ozakpinar OB, Eroglu M, et al. The impact of platelet functions and inflammatory status on the severity of preeclampsia. J. Matern. Fetal. Neonatal. Med. 2015;28(6):643-648. DOI: https://doi.org/10.3109/14767058.2014.927860Medvedev BI, Syundyukova EG, Sashenkov SL. [Preeclampsia Prevention Options]. Sovremennyye problemy nauki i obrazovaniya. 2017;2:83. Russian.Lipatov IS, Tezikov YuV, Prikhodko AV, et al. [The effectiveness of the prevention of preeclampsia and placental insufficiency. Bulletin of the medical institute &quot;REAVIZ&quot;: rehabilitation, doctor and health]. 2016;2(22):78-87. Russian.Khodzhaeva ZS, Kholin AM, Chulkov VS, et al. [Acetylsalicylic acid in the prevention of preeclampsia and associated obstetric and perinatal complications]. 2018;8:8-12. Russian. DOI: https://dx.doi.org/10.18565/aig.2018.8.12-18[WHO recommendations for the prevention and treatment of preeclampsia and eclampsia]. World Health Organization; 2014. Russian.